DelveInsight has launched a new report on “Aortic Stenosis Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Aortic Stenosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Aortic Stenosis, historical and forecasted epidemiology as well as the Aortic Stenosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Aortic Stenosis Market Report:
Request a sample for the Report: https://www.delveinsight.com/sample-request/calcific-aortic-valve-stenosis-cavs-epidemiology-forecast
Key benefits of the report:
Got queries? Click here to know more about the Aortic Stenosis Market Landscape
Aortic Stenosis Overview:
Aortic stenosis is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 years. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years.
Aortic stenosis has several etiologies, including congenital (unicuspid or bicuspid valve), acquired which includes degenerative calcification, and rheumatic heart disease. Degenerative calcific aortic stenosis is now the leading indication for aortic valve replacement. The favorable long-term outcome following aortic valve surgery and the relatively low operative risk emphasizes the importance of an accurate and timely diagnosis. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years. Exertional dyspnea or fatigue is the most common initial complaint. Ultimately, most patients experience the classic triad of chest pain, heart failure, and syncope. Stages of the condition include asymptomatic and symptomatic stages taking into consideration the valve hemodynamics.
Aortic Stenosis Symptoms:
The symptoms of Aortic Stenosis include –
Aortic Stenosis Market
The dynamics of the Aortic Stenosis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Edoxaban, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Aortic Stenosis Market Landscape
Aortic Stenosis Pipeline Therapies:
Aortic Stenosis Pipeline Key Companies:
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Aortic Stenosis Patient Share (%) Overview at a Glance
5. Aortic Stenosis Market Overview at a Glance
6. Aortic Stenosis Disease Background and Overview
7. Aortic Stenosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Aortic Stenosis
9. Aortic Stenosis Current Treatment and Medical Practices
10. Unmet Needs
11. Aortic Stenosis Emerging Therapies
12. Aortic Stenosis Market Outlook
13. Country-Wise Aortic Stenosis Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Aortic Stenosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about our Competitive Services, Click here: Pharma Competitive Intelligence
https://www.delveinsight.com/consulting/competitive-intelligence-services
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Gaurav BoraEmail: Send EmailPhone: +91 9568243403Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com